These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1703691)

  • 1. Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.
    Takaya S; Duquesnoy R; Iwaki Y; Demetris J; Yagihashi A; Bronsther O; Iwatsuki S; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):396-9. PubMed ID: 1703691
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
    Fung JJ; Todo S; Tzakis A; Demetris A; Jain A; Abu-Elmaged K; Alessiani M; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):14-21. PubMed ID: 1703682
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts.
    Lautenschlager I; Höckerstedt K; Mäkisalo H; Orko R; Taskinen E
    Transplant Proc; 1991 Aug; 23(4):2233-5. PubMed ID: 1714650
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation.
    Lee KK; Stangl MJ; Todo S; Langrehr JM; Hoffman A; Starzl TE; Schraut WH
    Transplant Proc; 1990 Dec; 22(6):2485-6. PubMed ID: 1702239
    [No Abstract]   [Full Text] [Related]  

  • 5. Morphological and immunological analysis of rats with long-term-surviving limb allografts induced by a short course of FK 506 or cyclosporine.
    Kuroki H; Ishida O; Daisaku H; Fukuhara K; Hatano E; Murakami T; Ikuta Y; Matsumoto AK; Akiyama M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):516-20. PubMed ID: 1703697
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
    Morris RE; Wu J; Shorthouse R
    Transplant Proc; 1990 Aug; 22(4):1638-41. PubMed ID: 1697111
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression.
    Imai K; Sato K; Takishima T; Nakayama Y; Osakabe T; Yokota K; Yamagishi K; Uchida H; Hiki Y
    Transplant Proc; 1990 Aug; 22(4):1655-7. PubMed ID: 1697117
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of immunosuppression in liver transplantation across a positive crossmatch.
    Lang M; Neumann U; Knoop M; Bechstein WO; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1466-7. PubMed ID: 9636595
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation.
    Neumann UP; Lang M; Moldenhauer A; Langrehr JM; Glanemann M; Kahl A; Frei U; Bechstein WO; Neuhaus P
    Transplantation; 2001 Apr; 71(8):1163-8. PubMed ID: 11374419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of FK 506 and cyclosporine on heart allograft survival in rats.
    Goto S; Stepkowski SM; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):529-30. PubMed ID: 1703700
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of FK 506 on heart allograft survival in highly sensitized recipient rats in comparison with cyclosporine.
    Jiang H; Takahara S; Takano Y; Li D; Kyo M; Valdivia LA; Kokado Y; Ishibashi M; Sonoda T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):540-1. PubMed ID: 1703702
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine.
    Sato K; Yokota K; Matsui T; Imai K; Takishima T; Nakayama Y; Osakabe T; Yoshida M; Mieno H; Omiya H
    Transplant Proc; 1991 Dec; 23(6):3296-9. PubMed ID: 1721440
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine and tacrolimus: a comparison of immunosuppressants used for liver transplantation.
    Shultz SL; Meriney DK
    Dimens Crit Care Nurs; 1996; 15(4):187-97. PubMed ID: 8717641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.
    Takaya S; Bronsther O; Abu-Elmagd K; Ramos H; Fung JJ; Todo S; Starzl TE
    Transplant Proc; 1993 Jun; 25(3):2381-5. PubMed ID: 7685953
    [No Abstract]   [Full Text] [Related]  

  • 15. Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
    Velio P; Tarantino C; Bertoglio C; Guffanti E; Bardella MT; Biffi R; Andreoni B; Rossi G; Gatti S; Piazzini A; Fassati LR; Galmarini D
    Transplant Proc; 1996 Oct; 28(5):2529-30. PubMed ID: 8907936
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
    Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
    Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
    [No Abstract]   [Full Text] [Related]  

  • 17. FK 506 and orthotopic liver transplantation in the rat.
    Isai H; Painter DM; Sheil AG
    Transplant Proc; 1990 Oct; 22(5):2125-6. PubMed ID: 1699329
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
    Fung JJ; Todo S; Jain A; McCauley J; Alessiani M; Scotti C; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):6-12. PubMed ID: 1689901
    [No Abstract]   [Full Text] [Related]  

  • 19. A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent.
    Staschak S; Wagner S; Block G; Van Thiel DH; Jain A; Fung J; Todo S; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):47-9. PubMed ID: 1689896
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy.
    Ben-Ari Z; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
    Transplant Proc; 2000 Jun; 32(4):709-10. PubMed ID: 10856553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.